ZMapp, an experimental drug that may have already have saved a few patients in Africa, is the most effective anti-Ebola therapy yet, according to a recent Nature paper on rhesus macaques monkeys.
A pharmacist who oversaw the sterile clean rooms at a Massachusetts compounding pharmacy responsible for a deadly meningitis outbreak was arrested Thursday as he was about to board a flight for Hong Kong, federal officials said.
At least $600 million is needed to fight the current Ebola outbreak in West Africa, which has now killed more than 1,900 people, the World Health Organization announced Wednesday.
A research team has devised a way to use magnetic resonance relaxometry (MRR), a close cousin of magnetic resonance imaging (MRI), to detect a parasitic waste product in the blood of Malaria-infected patients.
The international group Doctor Without Borders warned Tuesday that the world is `losing the battle' against Ebola, while U.N. officials implored all countries to quickly step up their response by contributing health experts and other help.
In response to an ongoing, unprecedented outbreak of Ebola virus disease (EVD) in West Africa, a team of researchers has rapidly sequenced and analyzed more than 99 Ebola virus genomes.
New research sheds light on how the rabies virus hijacks the transport system in nerve cells to reach the brain with maximal speed and efficiency.
Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus. The NIH announced today that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GSK.
A third top doctor has died from Ebola in Sierra Leone, a government official said Wednesday, as health workers tried to determine how a fourth scientist also contracted the disease before being evacuated to Europe.
Japanese health authorities have reported the first locally transmitted case of dengue fever in the country in more than 60 years. The ministry says the case occurred in Saitama, a prefecture adjacent to Tokyo.
The TIM family of proteins that promotes virus entry into cells also has the ability to block the release of HIV and other viruses, researchers have found.
A Liberian doctor who was among three Africans to receive an experimental Ebola drug has died, the country's information minister said Monday, as a top U.N. delegation promised more help for countries battling the virulent disease during a visit to Sierra Leone.
Two American aid workers have recovered from Ebola and left an Atlanta hospital, after weeks of intensive treatment in a special isolation unit. They were first two Ebola patients ever brought to the United States.
New research suggests a one-two punch could help battle polio in some of the world's most remote and strife-torn regions: Giving a single vaccine shot to children who've already swallowed drops of an oral polio vaccine greatly boosted their immunity.
Scientists who study tuberculosis have long debated its origins. New research shows that tuberculosis likely spread from humans in Africa to seals and sea lions that brought the disease to South America and transmitted it to Native people there before Europeans landed on the continent.
After nearly three weeks of treatment, the two American aid workers who were infected with the deadly Ebola virus in Africa have been discharged from an Atlanta hospital, officials said Thursday.
The enzyme phospholipase D (PLD) helps the influenza virus escape the immune response, and blocking it could lead to a new way to prevent the flu.
Scientists have made a breakthrough in the fight against the most resistant hospital superbugs by developing the first innovative antibacterial gel that acts to kill Pseudomonas aeruginosa, staphylococci and E. coli, using natural proteins.
The U.N. health agency says the Ebola outbreak in West Africa has now killed more than 1,200 people. The World Health Organization says the death toll has risen to 1,229 from among the 2,240 reported cases in Guinea, Liberia, Nigeria and Sierra Leone.
An estimated 55 million to 105 million people in the United States suffer from foodborne illnesses each year, according to the CDC, resulting in costs of $2 to $4 billion annually. What if Twitter could be used to track those cases and more quickly identify the source of the problem?
New research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on. The study helps scientists understand how different antibiotics affect good bacteria.
A scary problem lurks beyond the frenzied efforts to keep people from spreading Ebola: No one knows exactly where the virus comes from or how to stop it from seeding new outbreaks.
An investigation into a potentially dangerous blunder at a government lab found that a scientist kept silent about the accident and revealed it only after other employees noticed something fishy.
It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. Using plants this way — sometimes called "pharming" — can produce complex and valuable proteins for medicines.
An Iowa drug developer says it has enough doses of a possible vaccine for the deadly Ebola virus to launch an initial round of human testing. NewLink Genetics Chief Financial Officer Gordon Link says the timing of the trials is uncertain, but the company is receiving help from a number of sources to speed up the process.